Becker Capital Management Inc Pfizer Inc Transaction History

Becker Capital Management Inc

$2.9 Billion
Q2 2024

A detailed history of Becker Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Becker Capital Management Inc holds 963,763 shares of PFE stock, worth $28.7 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares

963,763

Previous 997,581 3.39%

Holding current value

$28.7 Million

Previous $27.7 Million 2.59%

% of portfolio

0.93%

Previous 0.95%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $854,242 - $1 Million	-33,818 Reduced 3.39%	963,763 $27 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $417,165 - $479,039	16,113 Added 1.64%	997,581 $27.7 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $1.69 Million - $2.2 Million	64,689 Added 7.06%	981,468 $28.3 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $1.31 Million - $1.54 Million	-40,976 Reduced 4.28%	916,779 $30.4 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $2.61 Million - $3.02 Million	72,328 Added 8.17%	957,755 $35.1 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $1.46 Million - $1.9 Million	37,020 Added 4.36%	885,427 $36.1 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $180,735 - $235,930	4,329 Added 0.51%	848,407 $43.5 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $603,669 - $736,928	-13,795 Reduced 1.61%	844,078 $36.9 Million
Q2 2022 Aug 04, 2022	SELL	$46.53 - $55.17 $1.16 Million - $1.38 Million	-25,008 Reduced 2.83%	857,873 $45 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $460,885 - $571,095	-10,074 Reduced 1.13%	882,881 $45.7 Million
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $1.11 Million - $1.65 Million	-26,861 Reduced 2.92%	892,955 $52.7 Million
Q3 2021 Oct 14, 2021	SELL	$39.25 - $50.42 $2.22 Million - $2.85 Million	-56,579 Reduced 5.79%	919,816 $39.6 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $375,977 - $425,919	10,470 Added 1.08%	976,395 $38.2 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $439,221 - $495,353	13,115 Added 1.38%	965,925 $35 Million
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $894,318 - $1.14 Million	-26,720 Reduced 2.73%	952,810 $35.1 Million
Q3 2020 Nov 09, 2020	SELL	$31.75 - $37.25 $760,857 - $892,659	-23,964 Reduced 2.39%	979,530 $35.9 Million
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $3.57 Million - $4.34 Million	-118,655 Reduced 10.57%	1,003,494 $32.8 Million
Q1 2020 May 07, 2020	SELL	$27.03 - $38.62 $4.9 Million - $7 Million	-181,168 Reduced 13.9%	1,122,149 $36.6 Million
Q4 2019 Feb 11, 2020	BUY	$32.92 - $37.36 $196,631 - $223,151	5,973 Added 0.46%	1,303,317 $51.1 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $1.23 Million - $1.6 Million	-37,911 Reduced 2.84%	1,297,344 $46.6 Million
Q2 2019 Aug 08, 2019	BUY	$36.98 - $41.52 $80,061 - $89,890	2,165 Added 0.16%	1,335,255 $57.8 Million
Q1 2019 May 08, 2019	SELL	$37.5 - $41.2 $4.47 Million - $4.91 Million	-119,161 Reduced 8.21%	1,333,090 $56.6 Million
Q4 2018 Feb 04, 2019	SELL	$38.47 - $43.86 $4.75 Million - $5.42 Million	-123,530 Reduced 7.84%	1,452,251 $63.4 Million
Q3 2018 Nov 05, 2018	SELL	$34.47 - $41.81 $1.56 Million - $1.89 Million	-45,235 Reduced 2.79%	1,575,781 $69.4 Million
Q2 2018 Aug 03, 2018	BUY	$32.98 - $35.16 $1.19 Million - $1.26 Million	35,974 Added 2.27%	1,621,016 $58.8 Million
Q1 2018 May 07, 2018	BUY	$31.91 - $37.02 $2.87 Million - $3.33 Million	90,068 Added 6.02%	1,585,042 $56.3 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $469,065 - $497,694	-14,103 Reduced 0.93%	1,494,974 $54.1 Million
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $680,419 - $749,558	21,949 Added 1.48%	1,509,077 $53.9 Million
Q2 2017 Aug 11, 2017	BUY	N/A	1,487,128	1,487,128 $50 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Becker Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Becker Capital Management Inc with notifications on news.

Account

Becker Capital Management Inc Pfizer Inc Transaction History